117 related articles for article (PubMed ID: 14499699)
1. Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases.
Meiboom M; Belge G; Bol S; El-Aouni C; Schoenmakers EF; Bullerdiek J
Cancer Genet Cytogenet; 2003 Oct; 146(1):70-2. PubMed ID: 14499699
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology.
Belge G; Roque L; Soares J; Bruckmann S; Thode B; Fonseca E; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Cancer Genet Cytogenet; 1998 Feb; 101(1):42-8. PubMed ID: 9460499
[TBL] [Abstract][Full Text] [Related]
3. [Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology].
Belge G; Roque L; Thode B; Fonseca E; Soares J; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Verh Dtsch Ges Pathol; 1997; 81():151-6. PubMed ID: 9474866
[TBL] [Abstract][Full Text] [Related]
4. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
[TBL] [Abstract][Full Text] [Related]
5. Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications.
Criado B; Barros A; Suijkerbuijk RF; Weghuis DO; Seruca R; Fonseca E; Castedo S
Am J Pathol; 1995 Jul; 147(1):136-44. PubMed ID: 7604875
[TBL] [Abstract][Full Text] [Related]
6. Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.
Belge G; Garcia E; Rippe V; Fusco A; Bartnitzke S; Bullerdiek J
Genes Chromosomes Cancer; 1997 Oct; 20(2):201-3. PubMed ID: 9331571
[TBL] [Abstract][Full Text] [Related]
7. A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors.
Rippe V; Belge G; Meiboom M; Kazmierczak B; Fusco A; Bullerdiek J
Genes Chromosomes Cancer; 1999 Nov; 26(3):229-36. PubMed ID: 10502321
[TBL] [Abstract][Full Text] [Related]
8. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Rippe V; Drieschner N; Meiboom M; Murua Escobar H; Bonk U; Belge G; Bullerdiek J
Oncogene; 2003 Sep; 22(38):6111-4. PubMed ID: 12955091
[TBL] [Abstract][Full Text] [Related]
9. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study.
Roque L; Serpa A; Clode A; Castedo S; Soares J
Lab Invest; 1999 Apr; 79(4):369-78. PubMed ID: 10211989
[TBL] [Abstract][Full Text] [Related]
10. FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.
Belge G; Garcia E; de Jong P; Bartnitzke S; Bullerdiek J
Cytogenet Cell Genet; 1995; 69(3-4):220-2. PubMed ID: 7698017
[TBL] [Abstract][Full Text] [Related]
11. Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.
Belge G; Rippe V; Meiboom M; Drieschner N; Garcia E; Bullerdiek J
Cytogenet Cell Genet; 2001; 93(1-2):48-51. PubMed ID: 11474178
[TBL] [Abstract][Full Text] [Related]
12. Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?
Belge G; Thode B; Bullerdiek J; Bartnitzke S
Cancer Genet Cytogenet; 1992 May; 60(1):23-6. PubMed ID: 1591702
[TBL] [Abstract][Full Text] [Related]
13. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
[TBL] [Abstract][Full Text] [Related]
14. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas.
Rippe V; Dittberner L; Lorenz VN; Drieschner N; Nimzyk R; Sendt W; Junker K; Belge G; Bullerdiek J
PLoS One; 2010 Mar; 5(3):e9485. PubMed ID: 20209130
[TBL] [Abstract][Full Text] [Related]
15. A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors.
Belge G; Thode B; Rippe V; Bartnitzke S; Bullerdiek J
Hum Genet; 1994 Aug; 94(2):198-202. PubMed ID: 8045569
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb.
Bol S; Belge G; Rippe V; Bullerdiek J
Cytogenet Cell Genet; 2001; 95(3-4):189-91. PubMed ID: 12063398
[TBL] [Abstract][Full Text] [Related]
17. A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas.
Meiboom M; Murua Escobar H; Pentimalli F; Fusco A; Belge G; Bullerdiek J
Cytogenet Genome Res; 2003; 101(2):113-7. PubMed ID: 14610350
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics of thyroid follicular adenomas.
van den Berg E; Oosterhuis JW; de Jong B; Buist J; Vos A; Dam A; Vermeij B
Cancer Genet Cytogenet; 1990 Feb; 44(2):217-22. PubMed ID: 2297682
[TBL] [Abstract][Full Text] [Related]
20. Detection of numerical chromosome anomalies in interphase cells of benign and malignant thyroid lesions using fluorescence in situ hybridization.
Barril N; Carvalho-Sales AB; Tajara EH
Cancer Genet Cytogenet; 2000 Feb; 117(1):50-6. PubMed ID: 10700867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
